Diabetes study: Medication
Official title Jockey Club Precision Prevention Programme on Young Onset Diabetes
ClinicalTrials.gov ID: NCT06693934
What this study is testing
What is Risk assessment with biogenetic and clinical test to predict diabetes risk?
Risk assessment with biogenetic and clinical test to predict diabetes risk is an investigational medicine, taken by mouth, being studied as a potential treatment for diabetes.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This is a community-based implementation program consisting of multiple components delivered by a multidisciplinary team to detect and prevent young onset diabetes with precision and value using biogenetic markers, digital tools, integrated care through public private partnership. Adults aged between 18 and 44 (inclusive) without known diabetes and with at least one risk factor for diabetes will undergo a saliva DNA and capillary blood test and complete a questionnaire.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 44. Healthy volunteers may be eligible.
You may be able to join if
- Aged between 18 and 44 years old
- With at least one risk factor for diabetes
You likely can't join if
- Known history of Diabetes
- With conditions considered not suitable by the project team (including illiteracy) The risk factors for diabetes include central or general obesity...
The study team makes the final eligibility decision.
Where it is enrolling
- Hong Kong, Hong Kong
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 44 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Hong Kong, Hong Kong. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.